IPO alert: Cancer-fighting startup Genprex raises millions going public to fund new treatments
March 29, 2018 at 15:18 PM EDT
Lung-cancer patients may have a bit more hope after Genprex Inc. shares debuted Thursday on the Nasdaq with an initial price of $5 — which also boosts the ranks of Austin's public companies. The company drastically reduced its proposed size of the offering.
